Reg FD Disclosure · Company Update

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 18, 2020 GENESCO INC . (Exact name of registrant as specified in its charter) Tennessee 1-3083 62-0211340 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)     1415 Murfreesboro Road Nashville Tennessee 37217-2895 (Address of Principal Executive Offices) (Zip Code) ( 615 ) 367-7000 Registrant's telephone number, including area code Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of exchange on which registered Common Stock, $1.00 par value GCO New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o ITEM 7.01. REGULATION FD DISCLOSURE. On March 18, 2020, Genesco Inc. (the "Company") issued a press release (the "Release") announcing that due to the heightened uncertainty relating to the potential impact of COVID-19 on the Company’s business operations, including its duration and effect on overall customer demand, the Company is withdrawing the full-fiscal year 2021 guidance issued on March 12, 2020. A copy of the Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. On March 17, 2020, the Company also submitted a borrowing request to draw $150.0 million under the Company’s Fourth Amended and Restated Credit Agreement dated January 31, 2018, as amended, as a precaution to ensure that funds are available to meet its obligations for a substantial period of time. The information contained in Item 7.01 and the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. ITEM 8.01. OTHER EVENTS. On March 18, 2020, the Company announced the temporary closure of all of its North American stores across its brands, effective March 18 until March 28, 2020. Customers can continue to shop online through the Company’s websites across all of the Company’s brands and regions. ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS. (d)       Exhibits The following exhibit is furnished herewith:         Exhibit Number      Description     99.1      Press Release dated March 18, 2020, issued by Genesco Inc. 104   Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.                 GENESCO INC.       Date: March 18, 2020   By:   /s/ Mel Tucker     Name:   Mel Tucker     Title:   Senior Vice President and Chief Financial Officer